Hrt Financial LP Xenon Pharmaceuticals Inc. Transaction History

Hrt Financial LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$38.14 - $45.74 $857,005 - $1.03 Million	-22,470 Reduced 75.81%	7,171 $281,000
Q3 2024 Nov 12, 2024	SELL	$36.12 - $43.96 $164,382 - $200,061	-4,551 Reduced 13.31%	29,641 $1.17 Million
Q2 2024 Aug 12, 2024	BUY	$36.25 - $43.75 $57,420 - $69,300	1,584 Added 4.86%	34,192 $1.33 Million
Q1 2024 May 13, 2024	SELL	$42.66 - $50.04 $2.15 Million - $2.53 Million	-50,461 Reduced 60.75%	32,608 $1.4 Million
Q4 2023 Feb 09, 2024	BUY	$28.7 - $46.46 $1.37 Million - $2.22 Million	47,859 Added 135.92%	83,069 $3.83 Million
Q3 2023 Nov 13, 2023	BUY	$34.16 - $39.73 $589,738 - $685,898	17,264 Added 96.2%	35,210 $1.2 Million
Q2 2023 Aug 11, 2023	BUY	$34.84 - $43.54 $625,238 - $781,368	17,946 New	17,946 $690,000
Q3 2022 Nov 14, 2022	SELL	$30.79 - $39.82 $122,390 - $158,284	-3,975 Reduced 19.97%	15,927 $574,000
Q2 2022 Aug 12, 2022	BUY	$25.44 - $35.16 $506,306 - $699,754	19,902 New	19,902 $605,000
Q4 2021 Feb 14, 2022	SELL	$15.6 - $35.4 $161,569 - $366,637	-10,357 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$14.86 - $19.45 $123,293 - $161,376	-8,297 Reduced 44.48%	10,357 $158,000
Q2 2021 Aug 16, 2021	SELL	$16.81 - $20.0 $37,385 - $44,480	-2,224 Reduced 10.65%	18,654 $347,000
Q1 2021 May 17, 2021	BUY	$13.65 - $21.31 $284,984 - $444,910	20,878 New	20,878 $373,000
Q1 2020 May 15, 2020	SELL	$8.08 - $17.57 $147,217 - $320,125	-18,220 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$8.11 - $14.65 $147,764 - $266,923	18,220 New	18,220 $238,000

217

69.6M

444K

207K

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $1.84B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.